Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | KBA1412 |
Synonyms | |
Therapy Description |
Limited information is currently available on KBA1412 (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
KBA1412 | KBA-1412|KBA 1412 | Limited information is currently available on KBA1412 (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05501821 | Phase I | KBA1412 + Pembrolizumab KBA1412 | Study of KBA1412 in Participants With Advanced Solid Malignant Tumors | Completed | NLD | BEL | 0 |